Balyasny Asset Management’s Fiserv Inc FISV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,600
Closed -$621K 3070
2025
Q2
$621K Sell
3,600
-2,900
-45% -$526K ﹤0.01% 2214
2025
Q1
$1.44M Buy
+6,500
New +$1.42M ﹤0.01% 1848
2024
Q4
Sell
-192,500
Closed -$34.6M 2901
2024
Q3
$34.6M Buy
192,500
+147,500
+328% +$24.3M 0.06% 426
2024
Q2
$6.71M Buy
+45,000
New +$6.81M 0.01% 1042
2022
Q2
Sell
-10,000
Closed -$1.01M 2880
2022
Q1
$1.01M Buy
+10,000
New +$1.01M ﹤0.01% 1618
2021
Q1
Sell
-20,000
Closed -$2.28M 1861
2020
Q4
$2.28M Hold
20,000
0.01% 848
2020
Q3
$2.06M Hold
20,000
0.02% 826
2020
Q2
$1.95M Buy
+20,000
New +$2.01M 0.02% 727
2019
Q4
Sell
-12,000
Closed -$1.24M 1256
2019
Q3
$1.24M Buy
+12,000
New +$1.23M 0.01% 786
2017
Q2
Sell
-100,000
Closed -$5.77M 1549
2017
Q1
$5.77M Buy
+100,000
New +$5.61M 0.03% 662

Other funds holding FISV

Balyasny Asset Management's FISV Position: Q1 2026 in Review

Balyasny Asset Management increased its Fiserv Inc (FISV) stake by 1,887% in Q1 2026, buying an estimated $14M and bringing the position to 238,119 shares worth $13.3M. The position accounts for 0.02% of the portfolio, ranked #881.

Balyasny Asset Management first reported a position in FISV in Q4 2015 and has held it in 29 quarters since. The position peaked at $111M in Q2 2020. 1,256 funds tracked by Wall St. Rank hold FISV as of Q1 2026.

  • Balyasny Asset Management held 238,119 shares of Fiserv Inc worth $13.3M as of Q1 2026.
  • Balyasny Asset Management bought 226,135 Fiserv Inc shares in Q1 2026, an estimated $14M.
  • Fiserv Inc made up 0.02% of Balyasny Asset Management's portfolio in Q1 2026, its #881 holding.
  • Balyasny Asset Management first reported a position in Fiserv Inc in Q4 2015 and has held it in 29 quarters since.
  • Balyasny Asset Management's Fiserv Inc position peaked at $111M in Q2 2020.
  • 1,256 funds tracked by Wall St. Rank held Fiserv Inc as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.